Thailand to Begin Its Covid-19 Vaccine Human Trials in September

July 12, 2020, 4:13 AM UTC

Thailand is starting the clinical stage for its own Covid-19 vaccine after both monkeys and mice generated satisfactory antibodies against the virus following injections, according to scientists in the study.

“We hope that the vaccine could generate neutralizing antibodies in humans seen in monkeys and mice,” Kiat Ruxrungtham, head researcher at Chulalongkorn University’s Center of Excellence in Vaccine Research and Development, said at a briefing on Sunday in Bangkok. If the trials are successful, Thailand could have its vaccine by the second half of 2021, he said.

Doses of a Covid-19 vaccine candidate ready for trial on monkeys at the National Primate Research Center of Thailand at Chulalongkorn University in May 2020.
Photographer: Mladen Antonov/AFP via Getty Images

The Thai study will begin its human trials as early ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.